PHARMACYTE BIOTECH, INC. Other Expenses
PHARMACYTE BIOTECH, INC. (PMCB) reported Other Expenses of $480 for the 3-month period ending 2021-10-31, per its 10-Q filed 2021-12-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2021-12-14
- PHARMACYTE BIOTECH, INC. other expenses for the quarter ending 2021-10-31 was $480.00.
- PHARMACYTE BIOTECH, INC. other expenses for the quarter ending 2021-07-31 was $1.60K, a 14.89% decline year-over-year.
- PHARMACYTE BIOTECH, INC. other expenses for the quarter ending 2021-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. other expenses for the quarter ending 2020-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. other expenses for fiscal 2011 was $730.28K.
| Period end | Other Expenses 3 month | Other Expenses 3 month as first filed | Other Expenses 6 month | Other Expenses 6 month as first filed | Other Expenses 9 month | Other Expenses 12 month |
|---|---|---|---|---|---|---|
| 2021-10-31 | $480.00 10-Q · filed 2021-12-14 | $2.08K 10-Q · filed 2021-12-14 | ||||
| 2021-07-31 | $1.60K 10-Q · filed 2021-09-14 | |||||
| 2021-01-31 | $0.00 10-Q · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-12-14 | $1.19K 10-Q · filed 2021-03-12 | |||
| 2020-10-31 | $0.00 10-Q · filed 2021-12-14 | $1.19K 10-Q · filed 2021-12-14 | ||||
| 2020-07-31 | $1.88K 10-Q · filed 2021-09-14 | |||||
| 2020-01-31 | $0.00 10-Q · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 10-Q · filed 2021-03-12 | |||
| 2019-10-31 | $0.00 10-Q · filed 2020-12-11 | $0.00 10-Q · filed 2020-12-11 | ||||
| 2019-07-31 | $0.00 10-Q · filed 2020-09-11 | |||||
| 2016-10-31 | $0.00 10-Q · filed 2016-12-02 | $0.00 10-Q · filed 2016-12-02 | ||||
| 2016-07-31 | $0.00 10-Q · filed 2016-09-06 | |||||
| 2015-10-31 | -$430.00 10-Q · filed 2016-12-02 | -$335.00 10-Q · filed 2016-12-02 | ||||
| 2015-07-31 | $95.00 10-Q · filed 2016-09-06 | |||||
| 2013-07-31 | $0.00 10-Q · filed 2013-09-16 | |||||
| 2013-01-31 | $0.00 10-Q · filed 2013-03-26 | $0.00 derived: sum of 2 quarters · filed 2013-03-26 | -$2.59K 10-Q · filed 2013-03-26 | |||
| 2012-10-31 | $0.00 10-Q · filed 2012-12-26 | -$2.59K 10-Q · filed 2012-12-26 | ||||
| 2012-07-31 | -$2.59K 10-Q · filed 2013-09-16 | $46.06K 10-Q · filed 2012-09-19 | ||||
| 2012-01-31 | $0.00 10-Q · filed 2013-03-26 | $0.00 derived: sum of 2 quarters · filed 2013-03-26 | $0.00 10-Q · filed 2013-03-26 | |||
| 2011-10-31 | $0.00 10-Q · filed 2012-12-26 | -$33.42K 10-Q · filed 2011-12-15 | $0.00 10-Q · filed 2012-12-26 | -$66.84K 10-Q · filed 2011-12-15 | ||
| 2011-07-31 | $33.42K 10-Q · filed 2012-09-19 | -$33.42K 10-Q/A · filed 2011-09-20 | ||||
| 2011-04-30 | $730.28K 10-K · filed 2012-08-14 | |||||
| 2010-10-31 | -$26.64K 10-Q · filed 2011-12-15 | -$81.57K 10-Q · filed 2011-12-15 | ||||
| 2010-07-31 | -$54.92K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |